Real-world risk of brain metastases in stage III non-small cell lung cancer in the era of PET and MRI staging

Real-world risk of brain metastases in stage III non-small cell lung cancer in the era of PET and MRI staging

ObjectiveThe 2-year incidence of brain metastases (BrMs) in stage III non-small lung cell cancer (NSCLC) has been estimated to be around 30%. However, recent clinical trials have demonstrated considerably lower BrMs rates in this patient population. In this study, we aimed to review the real-world i...

Full description

Bibliographic Details
Main Authors: Saud Alhusaini, Tyler A. Lanman, Ryan B. Ko, Kate E. Therkelsen, Rie Von Eyben, Maximilian Diehn, Scott G. Soltys, Erqi L. Pollom, Alexander Chin, Lucas Vitzthum, Heather A. Wakelee, Sukhmani K. Padda, Kavitha Ramchandran, Billy W. Loo, Joel W. Neal, Seema Nagpal
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Oncology
Subjects:
non-small cell lung cancer
brain metastases
incidence
surveillance
MRI brain
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1139940/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1139940/full

Similar Items